Drug-Induced Prolongation of the QT Interval.¶
Roden, D. M. (2004). Drug-Induced Prolongation of the QT Interval. New England Journal of Medicine, 350(11), 1013-1022.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Conjunctive Path Activation
- In pharmacology, a toxic pathway opens only under the AND of multiple drugs on board, a metabolic polymorphism, reduced renal function, and an electrolyte imbalance, each common and benign alone.
This sourceReviews the multifactorial risk structure for drug-induced QT prolongation and torsades de pointes — a toxic pathway realized only under the conjunction of QT-prolonging drugs, metabolic-enzyme inhibition/polymorphism, renal impairment, and electrolyte disturbance (hypokalemia/hypomagnesemia), each common and benign alone; also notes correlated stressors that raise joint risk.
- In pharmacology, a toxic pathway opens only under the AND of multiple drugs on board, a metabolic polymorphism, reduced renal function, and an electrolyte imbalance, each common and benign alone.
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:f7c019cd3a9d · see in the full table